Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H16N2O2 |
Molecular Weight | 208.2569 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CCC1=CC=C2OCOC2=C1)NN
InChI
InChIKey=IBWPUTAKVGZXRB-UHFFFAOYSA-N
InChI=1S/C11H16N2O2/c1-8(13-12)2-3-9-4-5-10-11(6-9)15-7-14-10/h4-6,8,13H,2-3,7,12H2,1H3
Molecular Formula | C11H16N2O2 |
Molecular Weight | 208.2569 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Safrazine (Safra) is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class that was introduced as an antidepressant in the 1960s. Safrazine and electroconvulsive therapy were shown to be effective in the treatment of antidepressant-resistant depressions (ARD) but had the drawbacks of the high incidence of moderate or severe adverse reactions and high relapse rates, respectively. The use of safrazine was discontinued.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095205 Sources: https://www.ncbi.nlm.nih.gov/pubmed/477139 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9916528
Nocturnal periodic hypoxemia occurring in a 25-year-old Duchenne muscular dystrophy patient under NIPPV control was successfully treated with monoamine oxydase inhibitor (MAOI), safrazine hydrochloride. Five mg of safrazine hydrochloride was administered before sleep, and the periodic hypoxemia disappeared within 14 days.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:17:21 GMT 2023
by
admin
on
Fri Dec 15 17:17:21 GMT 2023
|
Record UNII |
F5G0P5378C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C667
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID60860006
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
PRIMARY | |||
|
C013242
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
PRIMARY | |||
|
DB09253
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
PRIMARY | |||
|
34042
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
PRIMARY | |||
|
33419-68-0
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
PRIMARY | |||
|
Safrazine
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
PRIMARY | |||
|
100000078388
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
PRIMARY | |||
|
C84141
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
PRIMARY | |||
|
SUB15175MIG
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
PRIMARY | |||
|
F5G0P5378C
Created by
admin on Fri Dec 15 17:17:21 GMT 2023 , Edited by admin on Fri Dec 15 17:17:21 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |